BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15467768)

  • 1. An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Nakajima M; Faried A; Takita J; Sohda M; Fukai Y; Yamaguchi S; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Br J Cancer; 2004 Oct; 91(8):1556-60. PubMed ID: 15467768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Nakajima M; Sohda M; Fukai Y; Masuda N; Manda R; Fukuchi M; Tsukada K; Kuwano H
    Br J Cancer; 2003 Jul; 89(1):140-5. PubMed ID: 12838315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.
    Darnton SJ; Hardie LJ; Muc RS; Wild CP; Casson AG
    Int J Cancer; 2005 Jun; 115(3):351-8. PubMed ID: 15688381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
    Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
    Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative detection of TIMP-3 promoter hypermethylation and its prognostic significance in esophageal squamous cell carcinoma.
    Ninomiya I; Kawakami K; Fushida S; Fujimura T; Funaki H; Takamura H; Kitagawa H; Nakagawara H; Tajima H; Kayahara M; Ohta T
    Oncol Rep; 2008 Dec; 20(6):1489-95. PubMed ID: 19020732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
    Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
    Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion.
    Zhang H; Xu L; Xiao D; Xie J; Zeng H; Wang Z; Zhang X; Niu Y; Shen Z; Shen J; Wu X; Li E
    J Clin Pathol; 2007 May; 60(5):555-61. PubMed ID: 17412867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis on potential new molecular targets for esophageal cancer.
    Maurer J; Schöpp M; Thurau K; Haier J; Köhler G; Hummel R
    Dis Esophagus; 2014 Jan; 27(1):93-100. PubMed ID: 23551625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.
    Liu P; Chen S; Wu W; Liu B; Shen W; Wang F; He X; Zhang S
    Jpn J Clin Oncol; 2012 Jul; 42(7):612-8. PubMed ID: 22581910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients.
    Kozłowski M; Laudański W; Mroczko B; Szmitkowski M; Milewski R; Łapuć G
    Adv Med Sci; 2013; 58(2):227-34. PubMed ID: 23773968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
    Wan Y; Wu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Zheng X; Zhao Y; Wang X; Li Y; Wang R; Jiang Y; Gong T; Li M; Sun L; Hong L; Li X; Liang J; Luo G; Jin B; Yang J; Zhang H; Fan D
    Dig Dis Sci; 2010 Dec; 55(12):3408-14. PubMed ID: 20411424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].
    Liu JL; Zhou BJ; Zhang Y; Wu YP; Liu SZ; G A O WM; Xue J; Liu WH
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):689-92. PubMed ID: 18246800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus.
    Shibata H; Matsubara O; Wakiyama H; Tanaka S
    Pathol Res Pract; 2001; 197(3):157-64. PubMed ID: 11314778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
    Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
    Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.